A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies

Table 1 ELISA and IFAT comparative results for Plasmodium infected patients

IFAT and ELISA clinical sensitivities respectively 70.5% (67/95) (CI: 59.6% – 81%) and 84.2% (80/95) (CI: 76.2% – 92.2%), equivocal results considered as negative for calculation.

ISSN: 1475-2875